Does the Metabolic Syndrome accelerate the progression of coronary atherosclerosis independently of its component risk factors?
The accelerated progression of coronary atherosclerosis seen in metabolic syndrome is driven by its individual component risk factors rather than the syndrome as an independent entity.
Although accelerated disease progression is observed in the setting of MetS, this is owing to the presence of individual component risk factors rather than to the presence of the syndrome itself.
Özgür Bayturan (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: